Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. [electronic resource]
Producer: 20041012Description: 1502-12 p. digitalISSN:- 1533-4406
- Adenocarcinoma -- drug therapy
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Docetaxel
- Drug Resistance, Neoplasm
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prednisone -- administration & dosage
- Prostatic Neoplasms -- drug therapy
- Quality of Life
- Survival Analysis
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.